Exploratory Study on the Risk Factors and Prevention of Lipohypertrophy at Injection Sites of Insulin and GLP-1 Receptor Agonists in People with Type 2 Diabetes: A Collaborative Study with Certified Nurses in Diabetes Nursing

Exploratory Study on the Risk Factors and Prevention of Lipohypertrophy at Injection Sites of Insulin and GLP-1 Receptor Agonists in People with Type 2 Diabetes: A Collaborative Study with Certified Nurses in Diabetes Nursing - CNDN-LH study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059188

Enrollment

200

Registered

2025-09-25

Start date

2025-09-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age 4 or older 2) Type 2 diabetes 3) Receiving insulin therapy

Exclusion criteria

Exclusion criteria: Individuals deemed unsuitable for participation in the study by the principal investigator or co-investigators

Design outcomes

Primary

Measure	Time frame
The study will investigate the frequency of induration among participants, as well as its risk and protective factors, and will observe changes in HbA1c and other outcomes over approximately six months (24 weeks) following brief instruction on site rotation during routine clinical care.	—

Countries

Japan

Contacts

Public ContactSeiko Sakane

NHO Kyoto Medical Center Division of Preventive Medicine, Clinical Research Institute

404-j-doit1@mail.hosp.go.jp0756419161

Outcome results